Xiao Kang Liu
Direktor/Vorstandsmitglied bei PharmaLegacy Laboratories (Shanghai) Co., Ltd.
Ursprung des Netzwerks ersten Grades von Xiao Kang Liu
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China.
12
| Holding Company | Miscellaneous Commercial Services | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Xiao Kang Liu
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Stanford University | College/University | Graduate Degree | |
| Tongji University | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Oxford | College/University | Doctorate Degree | |
| Australian National University | College/University | Graduate Degree | |
| Indiana University | College/University | Masters Business Admin | |
| Yale University | College/University | Graduate Degree | |
| The University of Waterloo | College/University | Undergraduate Degree | |
| The Hong Kong University of Science & Technology | College/University | Undergraduate Degree | |
Citigroup Global Markets Asia Ltd.
 Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Shanghai International Studies University | College/University | Graduate Degree | |
| Shanghai Institute of Pharmaceutical Industry | College/University | Graduate Degree | |
| Tianjin Medical University | College/University | Graduate Degree | |
| Harbin Medical University | College/University | Undergraduate Degree | |
| University of North Texas Health Science Center | College/University | Doctorate Degree | |
| Shanghai University | College/University | Undergraduate Degree | |
| ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
| China Pharmaceutical University | College/University | Graduate Degree | |
| Chinese Academy of Medical Sciences | College/University | Doctorate Degree | |
| GUANGZHENG EYE HOSPITAL GROUP CO.,LTD. | Medical/Nursing Services | Director/Board Member | |
| Hebei University of Technology | College/University | Masters Business Admin | |
| Peking Union Medical College | College/University | Doctorate Degree | |
| Université Pierre-Mendès-France | College/University | Masters Business Admin | |
| CELLULAR BIOMEDICINE GROUP, INC. | Biotechnology | Director/Board Member | |
Genor Biopharma Co., Ltd.
 Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
| Temple University School of Medicine | College/University | Corporate Officer/Principal | |
| Shanghai Panxin Equity Investment Management Co. Ltd. | Chief Investment Officer | ||
| SUZHOU NANOMICRO TECHNOLOGY CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
| GEMPHARMATECH CO., LTD. | Biotechnology | Director/Board Member | |
| ZHAOKE OPHTHALMOLOGY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| GENOR BIOPHARMA HOLDINGS LIMITED | Biotechnology | Director/Board Member | |
| GRACELL BIOTECHNOLOGIES INC. | Biotechnology | Director/Board Member |
Statistik
International
| China | 16 |
| Vereinigte Staaten | 7 |
| Hong Kong | 4 |
| Cayman Islands | 4 |
| Vereinigtes Königreich | 2 |
Sektoral
| Consumer Services | 21 |
| Health Technology | 8 |
| Finance | 2 |
| Health Services | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 18 |
| Graduate Degree | 8 |
| Independent Dir/Board Member | 7 |
| Corporate Officer/Principal | 5 |
| Doctorate Degree | 4 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Guo Tong Xu | 11 |
| Yu Chen | 11 |
| Wen Jun Zhu | 3 |
| Jun Yi Li | 3 |
| Jeff Duan | 2 |
| Xin Huang | 2 |
| Jun Li | 2 |
| Xin Shu | 2 |
| Sheng Xue Mou | 2 |
| Zi Chun Ding | 2 |
| Yue Chi Zhang | 2 |
| Xu Chen Duan | 2 |
- Börse
- Insiders
- Xiao Kang Liu
- Unternehmensverbindungen
